Skip to main content

Table 4 The relationship between LPAR1 expression and prognosis

From: LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway

 

Primary samples

n = 74

P value

Primary samples

n = 74

P value

PFS < 12 months

n = 16

PFS ≥ 12 months

n = 58

OS < 36 months

n = 38

OS ≥ 36 months

n = 36

LPAR1

143.76 ± 18.93

136.65 ± 23.34

0.017a

148.20 ± 19.62

137.43 ± 26.67

0.039a

  1. Italic values indicate statistical significance (P < 0.05)
  2. LPAR1 lysophosphatidic acid receptor 1, PFS progression-free survival, OS overall survival
  3. aTwo samples rank sum test